The lawsuit targets Park Ha Biological Technology Co., Ltd. and certain officers over an alleged stock-promotion and market-manipulation scheme tied to purchases from December 27, 2024 to July 8, 2025.
Robbins LLP said a securities class action has been filed on behalf of investors who purchased or otherwise acquired Park Ha Biological Technology Co., Ltd. securities between December 27, 2024 and July 8, 2025. The complaint alleges Park Ha and certain officers misled investors and violated federal securities laws by failing to disclose material risks tied to an alleged fraudulent stock-promotion and market-manipulation scheme involving social media misinformation and people impersonating financial professionals. According to the filing, Park Ha’s stock rose from its $4.00 IPO price to a high of $41.49 on July 7, 2025 before collapsing the next day, closing at $2.99 after a 93% one-session drop that erased more than $1 billion in market capitalization. Investors who suffered losses during the class period may seek appointment as lead plaintiff by September 21, 2026.